Finecef-T 562.5mg Injection
Marketer
Abbott
Salt Composition
Ceftriaxone (500mg) + Tazobactum (62.5mg)
Overview Finecef-T 562.5mg Injection
Cefixime and Sulbactam injection, 562.5mg, is a dual-action antibiotic. It's indicated for a range of bacterial infections, inhibiting microbial growth and limiting infection spread. Administration must be overseen by a medical practitioner. Consistent adherence to the prescribed dosage schedule is crucial; complete the full course, regardless of symptom improvement. Premature cessation may compromise its effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects promptly to your physician. Seek immediate medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Inform your doctor of all current medications, including those for pre-existing conditions. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, avoid driving if experiencing somnolence or dizziness. Adequate rest, a balanced diet, and ample hydration are recommended for optimal recovery. Your doctor might order laboratory tests to monitor the medication's impact.
Primary Ingredients of Finecef-T 562.5mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Finecef-T 562.5mg Injection
Infections caused by bacteria
Major Benefits of Finecef-T 562.5mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Finecef-T 562.5mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Finecef-T 562.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Finecef-T 562.5mg Injection works:
The injectable formulation Finecef-T 562.5mg contains Ceftriaxone, a broad-spectrum antibiotic, and Tazobactum, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Tazobactum counters bacterial resistance mechanisms, thereby augmenting Ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
Alcohol consumption alongside Finecef-T 562.5mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable formulation of Finecef-T, 562.5mg, is typically deemed safe for pregnant individuals. Preclinical trials using animal models have indicated minimal or absent harm to the fetus; nonetheless, data from human studies are scarce.
Breast feedingCAUTION
Administering Finecef-T 562.5mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment and until the medication is fully cleared from her system.
DrivingUNSAFE
Administering Finecef-T 562.5mg Injection may induce drowsiness, visual disturbances, or dizziness. Driving should be avoided if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Finecef-T 562.5mg Injection administration to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation of Finecef-T (562.5mg) requires careful administration in individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Altering the Finecef-T (562.5mg) injection dose is generally unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Finecef-T 562.5mg Injection :
Omit a Finecef-T 562.5mg Injection dose? Seek your physician's advice.
Facts to Know About Finecef-T 562.5mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infectives |
3,018 People bought this recently